{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:38:55Z","timestamp":1787895535620,"version":"build-2784847793"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,7,29]],"date-time":"2012-07-29T00:00:00Z","timestamp":1343520000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s10549-012-2173-7","type":"journal-article","created":{"date-parts":[[2012,7,28]],"date-time":"2012-07-28T12:06:52Z","timestamp":1343477212000},"page":"555-569","source":"Crossref","is-referenced-by-count":46,"title":["Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women"],"prefix":"10.1007","volume":"135","author":[{"given":"A. J.","family":"Agboola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"Musa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Wanangwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Abdel-Fatah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. C.","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. A.","family":"Ayoade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Y.","family":"Oyebadejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"Banjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Deji-Agboola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. A.","family":"Rakha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. R.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. O.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,29]]},"reference":[{"issue":"5","key":"2173_CR1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3816\/CBC.2005.n.043","volume":"6","author":"GN Hortobagyi","year":"2005","unstructured":"Hortobagyi GN, de la Garza Salazar J, Pritchard K, Amadori D, Haidinger R, Hudis CA, Khaled H, Liu MC, Martin M, Namer M et al (2005) The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer 6(5):391\u2013401","journal-title":"Clin Breast Cancer"},{"key":"2173_CR2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2407-2-36","volume":"2","author":"CD Mathers","year":"2002","unstructured":"Mathers CD, Shibuya K, Boschi-Pinto C, Lopez AD, Murray CJ (2002) Global and regional estimates of cancer mortality and incidence by site: I. Application of regional cancer survival model to estimate cancer mortality distribution by site. BMC Cancer 2:36","journal-title":"BMC Cancer"},{"issue":"2","key":"2173_CR3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74\u2013108","journal-title":"CA Cancer J Clin"},{"issue":"17","key":"2173_CR4","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1158\/0008-5472.CAN-06-1927","volume":"66","author":"K Amend","year":"2006","unstructured":"Amend K, Hicks D, Ambrosone CB (2006) Breast cancer in African\u2013American women: differences in tumor biology from European\u2013American women. Cancer Res 66(17):8327\u20138330","journal-title":"Cancer Res"},{"issue":"9","key":"2173_CR5","first-page":"547","volume":"90","author":"TG Ijaduola","year":"1998","unstructured":"Ijaduola TG, Smith EB (1998) Pattern of breast cancer among white-American, African\u2013American, and nonimmigrant west-African women. J Natl Med Assoc 90(9):547\u2013551","journal-title":"J Natl Med Assoc"},{"issue":"3","key":"2173_CR6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3322\/canjclin.56.3.168","volume":"56","author":"C Smigal","year":"2006","unstructured":"Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL, Thun M (2006) Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin 56(3):168\u2013183","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"2173_CR7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/bcr932","volume":"6","author":"F Bray","year":"2004","unstructured":"Bray F, McCarron P, Parkin DM (2004) The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 6(6):229\u2013239","journal-title":"Breast Cancer Res"},{"issue":"14","key":"2173_CR8","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1200\/JCO.2005.05.2308","volume":"24","author":"F Kamangar","year":"2006","unstructured":"Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24(14):2137\u20132150","journal-title":"J Clin Oncol"},{"issue":"27","key":"2173_CR9","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1200\/JCO.2008.19.6873","volume":"27","author":"D Huo","year":"2009","unstructured":"Huo D, Ikpatt F, Khramtsov A, Dangou JM, Nanda R, Dignam J, Zhang B, Grushko T, Zhang C, Oluwasola O et al (2009) Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 27(27):4515\u20134521","journal-title":"J Clin Oncol"},{"issue":"8","key":"2173_CR10","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/cncr.20978","volume":"103","author":"A Fregene","year":"2005","unstructured":"Fregene A, Newman LA (2005) Breast cancer in sub-Saharan Africa: how does it relate to breast cancer in African\u2013American women? Cancer 103(8):1540\u20131550","journal-title":"Cancer"},{"issue":"2","key":"2173_CR11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.bjc.6604174","volume":"98","author":"RL Bowen","year":"2008","unstructured":"Bowen RL, Duffy SW, Ryan DA, Hart IR, Jones JL (2008) Early onset of breast cancer in a group of British black women. Br J Cancer 98(2):277\u2013281","journal-title":"Br J Cancer"},{"issue":"3","key":"2173_CR12","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1075-122X.2004.21324.x","volume":"10","author":"S Dindyal","year":"2004","unstructured":"Dindyal S, Ramdass MJ, Naraynsingh V, Jankey N, Maharaj D, Barrow S (2004) Relationship of ethnicity and histologic type of breast carcinoma in a West Indian population. Breast J 10(3):266","journal-title":"Breast J"},{"issue":"14","key":"2173_CR13","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","volume":"100","author":"T Sorlie","year":"2003","unstructured":"Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S et al (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100(14):8418\u20138423","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2173_CR14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ijc.21004","volume":"116","author":"DM Abd El-Rehim","year":"2005","unstructured":"Abd El-Rehim DM, Ball G, Pinder SE, Rakha E, Paish C, Robertson JF, Macmillan D, Blamey RW, Ellis IO (2005) High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer 116(3):340\u2013350","journal-title":"Int J Cancer"},{"issue":"9","key":"2173_CR15","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1158\/0008-5472.CAN-08-3907","volume":"69","author":"SE Elsheikh","year":"2009","unstructured":"Elsheikh SE, Green AR, Rakha EA, Powe DG, Ahmed RA, Collins HM, Soria D, Garibaldi JM, Paish CE, Ammar AA et al (2009) Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res 69(9):3802\u20133809","journal-title":"Cancer Res"},{"key":"2173_CR16","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/ijc.24860","volume":"126","author":"MA Aleskandarany","year":"2009","unstructured":"Aleskandarany MA, Green AR, Rakha EA, Mohammed RA, Elsheikh SE, Powe DG, Paish EC, Macmillan RD, Chan S, Ahmed SI et al (2009) Growth fraction as a predictor of response to chemotherapy in node negative breast cancer. Int J Cancer 126:1761\u20131769","journal-title":"Int J Cancer"},{"key":"2173_CR17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.canlet.2009.08.004","volume":"289","author":"M Frye","year":"2009","unstructured":"Frye M, Dragoni I, Chin SF, Spiteri I, Kurowski A, Provenzano E, Green A, Ellis IO, Grimmer D, Teschendorff A et al (2009) Genomic gain of 5p15 leads to over-expression of Misu (NSUN2) in breast cancer. Cancer Lett 289:71\u201380","journal-title":"Cancer Lett"},{"key":"2173_CR18","unstructured":"Elston CW, Ellis IO, Goulding H, Pinder SE (1998) Role of pathology in the prognosis and management of breast cancer, Systemic pathology, 3rd edn, chapt 18, vol 13. In: Elston CW, Ellis IO (eds) The Breast. Churchill Livingstone, Edinburgh"},{"issue":"6","key":"2173_CR19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s001090050128","volume":"75","author":"MW Beckmann","year":"1997","unstructured":"Beckmann MW, Niederacher D, Schnurch HG, Gusterson BA, Bender HG (1997) Multistep carcinogenesis of breast cancer and tumour heterogeneity. J Mol Med 75(6):429\u2013439","journal-title":"J Mol Med"},{"issue":"21","key":"2173_CR20","first-page":"2498","volume":"121","author":"A Forus","year":"2001","unstructured":"Forus A, Sorlie T, Borresen-Dale AL, Myklebost O (2001) Microarray technology\u2014potential in cancer research. Tidsskr Nor Laegeforen 121(21):2498\u20132503","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"16","key":"2173_CR21","doi-asserted-by":"crossref","first-page":"9212","DOI":"10.1073\/pnas.96.16.9212","volume":"96","author":"CM Perou","year":"1999","unstructured":"Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, Ross DT, Pergamenschikov A, Williams CF, Zhu SX, Lee JC et al (1999) Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA 96(16):9212\u20139217","journal-title":"Proc Natl Acad Sci USA"},{"issue":"19","key":"2173_CR22","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T Sorlie","year":"2001","unstructured":"Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Nat Acad Sci USA 98(19):10869\u201310874","journal-title":"Proc Nat Acad Sci USA"},{"issue":"6871","key":"2173_CR23","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/415530a","volume":"415","author":"LJ \u2018t Veer van","year":"2002","unstructured":"van \u2018t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT et al (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415(6871):530\u2013536","journal-title":"Nature"},{"issue":"25","key":"2173_CR24","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1056\/NEJMoa021967","volume":"347","author":"MJ Vijver van de","year":"2002","unstructured":"van de Vijver MJ, He YD, van \u2018t Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ et al (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347(25):1999\u20132009","journal-title":"N Engl J Med"},{"issue":"9","key":"2173_CR25","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.humpath.2006.04.015","volume":"37","author":"MJ Kim","year":"2006","unstructured":"Kim MJ, Ro JY, Ahn SH, Kim HH, Kim SB, Gong G (2006) Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2\/neu-overexpressing phenotypes. Hum Pathol 37(9):1217\u20131226","journal-title":"Hum Pathol"},{"issue":"2","key":"2173_CR26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jso.21307","volume":"100","author":"J Zhao","year":"2009","unstructured":"Zhao J, Liu H, Wang M, Gu L, Guo X, Gu F, Fu L (2009) Characteristics and prognosis for molecular breast cancer subtypes in Chinese women. J Surg Oncol 100(2):89\u201394","journal-title":"J Surg Oncol"},{"issue":"21","key":"2173_CR27","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","volume":"295","author":"LA Carey","year":"2006","unstructured":"Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295(21):2492\u20132502","journal-title":"JAMA"},{"issue":"3","key":"2173_CR28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/A:1016361932220","volume":"74","author":"KC Chu","year":"2002","unstructured":"Chu KC, Anderson WF (2002) Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial\/ethnic groups. Breast Cancer Res Treat 74(3):199\u2013211","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"2173_CR29","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1159\/000164270","volume":"31","author":"SJ Cleator","year":"2008","unstructured":"Cleator SJ, Palmieri C, Coombes CR (2008) The ethnic profile of triple-negative breast cancer. Onkologie 31(11):580\u2013582","journal-title":"Onkologie"},{"issue":"15","key":"2173_CR30","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/jnci\/djm059","volume":"99","author":"AG Glass","year":"2007","unstructured":"Glass AG, Lacey JV Jr, Carreon JD, Hoover RN (2007) Breast cancer incidence, 1980\u20132006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 99(15):1152\u20131161","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"2173_CR31","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/sj.bjc.6602184","volume":"91","author":"DM Abd El-Rehim","year":"2004","unstructured":"Abd El-Rehim DM, Pinder SE, Paish CE, Bell JA, Rampaul RS, Blamey RW, Robertson JF, Nicholson RI, Ellis IO (2004) Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma. Br J Cancer 91(8):1532\u20131542","journal-title":"Br J Cancer"},{"issue":"18","key":"2173_CR32","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1016\/j.ejca.2006.08.015","volume":"42","author":"EA Rakha","year":"2006","unstructured":"Rakha EA, El-Rehim DA, Paish C, Green AR, Lee AH, Robertson JF, Blamey RW, Macmillan D, Ellis IO (2006) Basal phenotype identifies a poor prognostic subgroup of BC of clinical importance. Eur J Cancer 42(18):3149\u20133156","journal-title":"Eur J Cancer"},{"issue":"1","key":"2173_CR33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.22381","volume":"109","author":"EA Rakha","year":"2007","unstructured":"Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO (2007) Prognostic markers in triple-negative breast cancer. Cancer 109(1):25\u201332","journal-title":"Cancer"},{"issue":"5","key":"2173_CR34","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/path.1357","volume":"200","author":"Z Madjd","year":"2003","unstructured":"Madjd Z, Pinder SE, Paish C, Ellis IO, Carmichael J, Durrant LG (2003) Loss of CD59 expression in breast tumours correlates with poor survival. J Pathol 200(5):633\u2013639","journal-title":"J Pathol"},{"issue":"36","key":"2173_CR35","doi-asserted-by":"crossref","first-page":"9067","DOI":"10.1200\/JCO.2004.01.0454","volume":"23","author":"LM McShane","year":"2005","unstructured":"McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2005) Reporting recommendations for tumor marker prognostic studies. J Clin Oncol 23(36):9067\u20139072","journal-title":"J Clin Oncol"},{"issue":"7","key":"2173_CR36","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nm0798-844","volume":"4","author":"J Kononen","year":"1998","unstructured":"Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4(7):844\u2013847","journal-title":"Nat Med"},{"issue":"4","key":"2173_CR37","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/path.2663","volume":"220","author":"TM Abdel-Fatah","year":"2010","unstructured":"Abdel-Fatah TM, Powe DG, Agboola J, Adamowicz-Brice M, Blamey RW, Lopez-Garcia MA, Green AR, Reis-Filho JS, Ellis IO (2010) The biological, clinical and prognostic implications of p53 transcriptional pathways in breast cancers. J Pathol 220(4):419\u2013434","journal-title":"J Pathol"},{"issue":"6","key":"2173_CR38","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2559.2005.02156.x","volume":"46","author":"EA Rakha","year":"2005","unstructured":"Rakha EA, Abd El Rehim D, Pinder SE, Lewis SA, Ellis IO (2005) E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance. Histopathology 46(6):685\u2013693","journal-title":"Histopathology"},{"issue":"1","key":"2173_CR39","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","volume":"25","author":"AC Wolff","year":"2007","unstructured":"Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A et al (2007) American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25(1):118\u2013145","journal-title":"J Clin Oncol"},{"issue":"4","key":"2173_CR40","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2559.2010.03503.x","volume":"56","author":"T Garcia-Caballero","year":"2010","unstructured":"Garcia-Caballero T, Grabau D, Green AR, Gregory J, Schad A, Kohlwes E, Ellis IO, Watts S, Mollerup J (2010) Determination of HER2 amplification in primary breast cancer using dual-colour chromogenic in situ hybridization is comparable to fluorescence in situ hybridization: a European multicentre study involving 168 specimens. Histopathology 56(4):472\u2013480","journal-title":"Histopathology"},{"issue":"16","key":"2173_CR41","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","volume":"10","author":"TO Nielsen","year":"2004","unstructured":"Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L et al (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clinical cancer research. J Am Assoc Cancer Res 10(16):5367\u20135374","journal-title":"J Am Assoc Cancer Res"},{"issue":"1","key":"2173_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1006052115874","volume":"53","author":"M Sundquist","year":"1999","unstructured":"Sundquist M, Thorstenson S, Brudin L, Nordenskjold B (1999) Applying the Nottingham prognostic index to a Swedish breast cancer population. South East Swedish Breast Cancer Study Group. Breast Cancer Res Treat 53(1):1\u20138","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"2173_CR43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01840834","volume":"22","author":"MH Galea","year":"1992","unstructured":"Galea MH, Blamey RW, Elston CE, Ellis IO (1992) The Nottingham prognostic index in primary breast cancer. Breast Cancer Res Treat 22(3):207\u2013219","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"2173_CR44","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/1097-0142(19911115)68:10<2142::AID-CNCR2820681010>3.0.CO;2-D","volume":"68","author":"DE Henson","year":"1991","unstructured":"Henson DE, Ries L, Freedman LS, Carriaga M (1991) Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index. Cancer 68(10):2142\u20132149","journal-title":"Cancer"},{"issue":"3","key":"2173_CR45","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00005650-199703000-00004","volume":"35","author":"PM Lantz","year":"1997","unstructured":"Lantz PM, Weigers ME, House JS (1997) Education and income differentials in breast and cervical cancer screening. Policy implications for rural women. Med Care 35(3):219\u2013236","journal-title":"Med Care"},{"issue":"8","key":"2173_CR46","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1023\/A:1011240019516","volume":"12","author":"K Yost","year":"2001","unstructured":"Yost K, Perkins C, Cohen R, Morris C, Wright W (2001) Socioeconomic status and breast cancer incidence in California for different race\/ethnic groups. Cancer Causes Control 12(8):703\u2013711","journal-title":"Cancer Causes Control"},{"issue":"5","key":"2173_CR47","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/cncr.11604","volume":"98","author":"I Jatoi","year":"2003","unstructured":"Jatoi I, Becher H, Leake CR (2003) Widening disparity in survival between white and African\u2013American patients with breast carcinoma treated in the U. S. Department of Defense Healthcare system. Cancer 98(5):894\u2013899","journal-title":"Cancer"},{"issue":"3","key":"2173_CR48","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1200\/JCO.2004.04.067","volume":"22","author":"H Brenner","year":"2004","unstructured":"Brenner H, Hakulinen T (2004) Are patients diagnosed with breast cancer before age 50\u00a0years ever cured? J Clin Oncol 22(3):432\u2013438","journal-title":"J Clin Oncol"},{"issue":"3","key":"2173_CR49","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2559.1995.tb00213.x","volume":"27","author":"H Pereira","year":"1995","unstructured":"Pereira H, Pinder SE, Sibbering DM, Galea MH, Elston CW, Blamey RW, Robertson JF, Ellis IO (1995) Pathological prognostic factors in breast cancer. IV: should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma. Histopathology 27(3):219\u2013226","journal-title":"Histopathology"},{"issue":"4","key":"2173_CR50","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/bcr2607","volume":"12","author":"EA Rakha","year":"2010","unstructured":"Rakha EA, Reis-Filho JS, Baehner F, Dabbs DJ, Decker T, Eusebi V, Fox SB, Ichihara S, Jacquemier J, Lakhani SR et al (2010) Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res 12(4):207","journal-title":"Breast Cancer Res"},{"issue":"1","key":"2173_CR51","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10549-007-9694-5","volume":"110","author":"CA Adebamowo","year":"2008","unstructured":"Adebamowo CA, Famooto A, Ogundiran TO, Aniagwu T, Nkwodimmah C, Akang EE (2008) Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res Treat 110(1):183\u2013188","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"2173_CR52","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4103\/1117-1936.177188","volume":"14","author":"EK Abudu","year":"2007","unstructured":"Abudu EK, Banjo AA, Izegbu MC, Agboola AO, Anunobi CC, Musa OA (2007) Malignant Breast Lessions At Olabisi Onabanjo University Teaching Hospital (O.O.U.T.H), Sagamu\u2014a histopathological review. Niger Postgrad Med J 14(1):57\u201359","journal-title":"Niger Postgrad Med J"},{"issue":"4","key":"2173_CR53","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/cncr.22836","volume":"110","author":"GJ Morris","year":"2007","unstructured":"Morris GJ, Naidu S, Topham AK, Guiles F, Xu Y, McCue P, Schwartz GF, Park PK, Rosenberg AL, Brill K et al (2007) Differences in breast carcinoma characteristics in newly diagnosed African\u2013American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute\u2019s surveillance, epidemiology, and end results database. Cancer 110(4):876\u2013884","journal-title":"Cancer"},{"issue":"2","key":"2173_CR54","first-page":"120","volume":"19","author":"SN Anyanwu","year":"2000","unstructured":"Anyanwu SN (2000) Breast cancer in eastern Nigeria: a ten year review. West Afr J Med 19(2):120\u2013125","journal-title":"West Afr J Med"},{"issue":"11","key":"2173_CR55","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s00268-008-9712-8","volume":"32","author":"H Nakajima","year":"2008","unstructured":"Nakajima H, Fujiwara I, Mizuta N, Sakaguchi K, Hachimine Y, Konishi E, Yanagisawa A, Magae J (2008) Prognosis of Japanese breast cancer based on hormone receptor and HER2 expression determined by immunohistochemical staining. World J Surg 32(11):2477\u20132482","journal-title":"World J Surg"},{"issue":"6","key":"2173_CR56","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3322\/canjclin.53.6.342","volume":"53","author":"A Ghafoor","year":"2003","unstructured":"Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R, Thun M (2003) Trends in breast cancer by race and ethnicity. CA Cancer J Clin 53(6):342\u2013355","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"2173_CR57","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1007\/s00268-008-9589-6","volume":"32","author":"A Kwong","year":"2008","unstructured":"Kwong A, Cheung P, Chan S, Lau S (2008) Breast cancer in Chinese women younger than age 40: are they different from their older counterparts? World J Surg 32(12):2554\u20132561","journal-title":"World J Surg"},{"issue":"3","key":"2173_CR58","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.breast.2005.06.008","volume":"15","author":"AR Adesunkanmi","year":"2006","unstructured":"Adesunkanmi AR, Lawal OO, Adelusola KA, Durosimi MA (2006) The severity, outcome and challenges of breast cancer in Nigeria. Breast 15(3):399\u2013409","journal-title":"Breast"},{"issue":"1","key":"2173_CR59","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2307\/30032445","volume":"10","author":"VJ Ekanem","year":"2006","unstructured":"Ekanem VJ, Aligbe JU (2006) Histopathological types of breast cancer in Nigerian women: a 12-year review (1993\u20132004). Afr J Reprod Health 10(1):71\u201375","journal-title":"Afr J Reprod Health"},{"issue":"3","key":"2173_CR60","first-page":"209","volume":"24","author":"ID Gukas","year":"2005","unstructured":"Gukas ID, Jennings BA, Mandong BM, Igun GO, Girling AC, Manasseh AN, Ugwu BT, Leinster SJ (2005) Clinicopathological features and molecular markers of breast cancer in Jos, Nigeria. West Afr J Med 24(3):209\u2013213","journal-title":"West Afr J Med"},{"issue":"3","key":"2173_CR61","first-page":"159","volume":"37","author":"I Hassan","year":"1992","unstructured":"Hassan I, Onukak EE, Mabogunje OA (1992) Breast cancer in Zaria, Nigeria. J R Coll Surg Edinb 37(3):159\u2013161","journal-title":"J R Coll Surg Edinb"},{"issue":"3","key":"2173_CR62","first-page":"179","volume":"19","author":"CA Adebamowo","year":"2000","unstructured":"Adebamowo CA, Ajayi OO (2000) Breast cancer in Nigeria. West Afr J Med 19(3):179\u2013191","journal-title":"West Afr J Med"},{"key":"2173_CR63","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/1471-2407-6-271","volume":"6","author":"OA Oluwatosin","year":"2006","unstructured":"Oluwatosin OA, Oladepo O (2006) Knowledge of breast cancer and its early detection measures among rural women in Akinyele Local Government Area, Ibadan, Nigeria. BMC Cancer 6:271","journal-title":"BMC Cancer"},{"issue":"1","key":"2173_CR64","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.breast.2005.02.003","volume":"15","author":"ID Gukas","year":"2006","unstructured":"Gukas ID, Jennings BA, Mandong BM, Manasseh AN, Harvey I, Leinster SJ (2006) A comparison of the pattern of occurrence of breast cancer in Nigerian and British women. Breast 15(1):90\u201395","journal-title":"Breast"},{"issue":"11\u201312","key":"2173_CR65","first-page":"122","volume":"49","author":"OF Ikpatt","year":"2003","unstructured":"Ikpatt OF, Ndoma-Egba R (2003) Oestrogen and progesterone receptors in Nigerian breast cancer: relationship to tumour histopathology and survival of patients. Cent Afr J Med 49(11\u201312):122\u2013126","journal-title":"Cent Afr J Med"},{"issue":"21","key":"2173_CR66","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1002\/cncr.25276","volume":"116","author":"A Stark","year":"2010","unstructured":"Stark A, Kleer CG, Martin I, Awuah B, Nsiah-Asare A, Takyi V, Braman M, Quayson SE, Zarbo R, Wicha M et al (2010) African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study. Cancer 116(21):4926\u20134932","journal-title":"Cancer"},{"issue":"1","key":"2173_CR67","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10549-007-9694-5","volume":"110","author":"CA Adebamowo","year":"2007","unstructured":"Adebamowo CA, Famooto A, Ogundiran TO, Aniagwu T, Nkwodimmah C, Akang EE (2007) Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res Treat 110(1):183\u2013188","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"2173_CR68","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/ajhb.20709","volume":"20","author":"FL Jackson","year":"2008","unstructured":"Jackson FL (2008) Ancestral links of Chesapeake Bay region African Americans to specific Bight of Bonny (West Africa) microethnic groups and increased frequency of aggressive breast cancer in both regions. Am J Hum Biol 20(2):165\u2013173","journal-title":"Am J Hum Biol"},{"issue":"16","key":"2173_CR69","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1158\/1078-0432.CCR-04-2421","volume":"11","author":"R Rouzier","year":"2005","unstructured":"Rouzier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, Anderson K, Hess KR, Stec J, Ayers M, Wagner P et al (2005) Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 11(16):5678\u20135685","journal-title":"Clin Cancer Res"},{"issue":"17","key":"2173_CR70","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1158\/1078-0432.CCR-04-0110","volume":"10","author":"G Arpino","year":"2004","unstructured":"Arpino G, Green SJ, Allred DC, Lew D, Martino S, Osborne CK, Elledge RM (2004) HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study. Clin Cancer Res 10(17):5670\u20135676","journal-title":"Clin Cancer Res"},{"issue":"12","key":"2173_CR71","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1002\/cncr.20279","volume":"100","author":"PL Porter","year":"2004","unstructured":"Porter PL, Lund MJ, Lin MG, Yuan X, Liff JM, Flagg EW, Coates RJ, Eley JW (2004) Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma. Cancer 100(12):2533\u20132542","journal-title":"Cancer"},{"issue":"29","key":"2173_CR72","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.1200\/JCO.2005.03.3845","volume":"23","author":"JD Brenton","year":"2005","unstructured":"Brenton JD, Carey LA, Ahmed AA, Caldas C (2005) Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol 23(29):7350\u20137360","journal-title":"J Clin Oncol"},{"issue":"4","key":"2173_CR73","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/onc.2008.405","volume":"28","author":"J Wen","year":"2009","unstructured":"Wen J, Li R, Lu Y, Shupnik MA (2009) Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions. Oncogene 28(4):575\u2013586","journal-title":"Oncogene"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-012-2173-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-012-2173-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-012-2173-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T15:46:44Z","timestamp":1714232804000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-012-2173-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,29]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["2173"],"URL":"https:\/\/doi.org\/10.1007\/s10549-012-2173-7","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,29]]}}}